Futura Medical plc announced the appointment of Ken James, the former head of consumer healthcare R&D at GlaxoSmithKline plc (GSK), as a Non-Executive Director, with effect from 31 March 2016. Mr. James has more than 40 years' experience of healthcare R&D, having joined one of GSK's predecessor businesses, Beecham Products, in 1973. Mr. James recently retired from GSK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40 GBX | +0.76% | -1.48% | +56.86% |
Apr. 10 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
Apr. 10 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.86% | 150M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- FUM Stock
- News Futura Medical plc
- Futura Medical plc Appoints Ken James as Non-Executive Director, Effective from 31 March 2016